205 related articles for article (PubMed ID: 30410015)
1. Prognostic role of the systemic immune-inflammation index in brain metastases from lung adenocarcinoma with different EGFR mutations.
Li H; Wang G; Zhang H; Song X; Cao J; Zhang X; Xue R; Wang W; Jia S; Li Z
Genes Immun; 2019 Jul; 20(6):455-461. PubMed ID: 30410015
[TBL] [Abstract][Full Text] [Related]
2. Dynamic changes in the systemic immune-inflammation index predict the prognosis of EGFR-mutant lung adenocarcinoma patients receiving brain metastasis radiotherapy.
Wang Q; Tan X; Deng G; Fu S; Li J; Li Z
BMC Pulm Med; 2022 Mar; 22(1):75. PubMed ID: 35241046
[TBL] [Abstract][Full Text] [Related]
3. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy.
Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G
Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
[TBL] [Abstract][Full Text] [Related]
4. High systemic immune-inflammation index predicts poor prognosis in advanced lung adenocarcinoma patients treated with EGFR-TKIs.
Deng C; Zhang N; Wang Y; Jiang S; Lu M; Huang Y; Ma J; Hu C; Hou T
Medicine (Baltimore); 2019 Aug; 98(33):e16875. PubMed ID: 31415428
[TBL] [Abstract][Full Text] [Related]
5. Pre-radiotherapy systemic immune inflammation index associated with overall survival in patients with advanced EGFR mutant non-small cell lung cancer receiving thoracic radiotherapy.
Chen D; Qin H; Deng G; Wang Q; Wang H; Liu X
Clin Transl Oncol; 2023 Jan; 25(1):226-235. PubMed ID: 36070068
[TBL] [Abstract][Full Text] [Related]
6. Prognostic model for brain metastases from lung adenocarcinoma identified with epidermal growth factor receptor mutation status.
Li H; Wang W; Jia H; Lian J; Cao J; Zhang X; Song X; Jia S; Li Z; Cao X; Zhou W; Han S; Yang W; Xi Y; Lian S
Thorac Cancer; 2017 Sep; 8(5):436-442. PubMed ID: 28597503
[TBL] [Abstract][Full Text] [Related]
7. Additional prognostic role of EGFR activating mutations in lung adenocarcinoma patients with brain metastasis: integrating with lung specific GPA score.
Lee DW; Shin DY; Kim JW; Keam B; Kim TM; Kim HJ; Kim DW; Wu HG; Paek SH; Kim YW; Heo DS; Kim DG; Lee SH
Lung Cancer; 2014 Dec; 86(3):363-8. PubMed ID: 25453849
[TBL] [Abstract][Full Text] [Related]
8. Impact of epidermal growth factor receptor mutations on intracranial treatment response and survival after brain metastases in lung adenocarcinoma patients.
Hsiao SH; Lin HC; Chou YT; Lin SE; Kuo CC; Yu MC; Chung CL
Lung Cancer; 2013 Sep; 81(3):455-461. PubMed ID: 23871711
[TBL] [Abstract][Full Text] [Related]
9. Assessment of prognostic scores of brain metastases from lung adenocarcinoma with EGFR mutations.
Li H; Lian J; Jin H; Wang W; Cao J; Zhang X; Song X; Jia S; Jia H; Ren J; Han S; Yang W; Xi Y; Lan S
J Neurooncol; 2017 May; 133(1):129-135. PubMed ID: 28391386
[TBL] [Abstract][Full Text] [Related]
10. A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis?
Han G; Bi J; Tan W; Wei X; Wang X; Ying X; Guo X; Zhou X; Hu D; Zhen W
Oncotarget; 2016 Aug; 7(35):56998-57010. PubMed ID: 27486770
[TBL] [Abstract][Full Text] [Related]
11. Systemic immune-inflammation index predicts prognosis in patients with different EGFR-mutant lung adenocarcinoma.
Ju Q; Huang T; Zhang Y; Wu L; Geng J; Mu X; Yan T; Zhang J
Medicine (Baltimore); 2021 Feb; 100(6):e24640. PubMed ID: 33578585
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
[TBL] [Abstract][Full Text] [Related]
13. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer.
Guo W; Cai S; Zhang F; Shao F; Zhang G; Zhou Y; Zhao L; Tan F; Gao S; He J
Thorac Cancer; 2019 Apr; 10(4):761-768. PubMed ID: 30734516
[TBL] [Abstract][Full Text] [Related]
14. The prognostic effect of the epidermal growth factor receptor gene mutation on recurrence dynamics of lung adenocarcinoma.
Park IK; Hyun K; Kim ER; Park S; Kang CH; Kim YT
Eur J Cardiothorac Surg; 2018 Dec; 54(6):1022-1027. PubMed ID: 29878144
[TBL] [Abstract][Full Text] [Related]
15. Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer.
Yan X; Li G
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32175568
[TBL] [Abstract][Full Text] [Related]
16. Correlation between status of epidermal growth factor receptor mutation and distant metastases of lung adenocarcinoma upon initial diagnosis based on 1063 patients in China.
Li H; Cao J; Zhang X; Song X; Wang W; Jia S; Li Z; Jia H; Cao X; Zhou W; Lian J; Han S; Yang W; Xi Y; Lian S; Jing H
Clin Exp Metastasis; 2017 Jan; 34(1):63-71. PubMed ID: 27888377
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases.
Xu J; Yang Y; Gao Z; Song T; Ma Y; Yu X; Shi C
Clin Neurol Neurosurg; 2024 May; 240():108258. PubMed ID: 38552362
[TBL] [Abstract][Full Text] [Related]
18. Sensitive detection of EGFR mutations in cerebrospinal fluid from lung adenocarcinoma patients with brain metastases.
Yang H; Cai L; Zhang Y; Tan H; Deng Q; Zhao M; Xu X
J Mol Diagn; 2014 Sep; 16(5):558-563. PubMed ID: 24994671
[TBL] [Abstract][Full Text] [Related]
19. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.
Tong YS; Tan J; Zhou XL; Song YQ; Song YJ
J Transl Med; 2017 Oct; 15(1):221. PubMed ID: 29089030
[TBL] [Abstract][Full Text] [Related]
20. Micropapillary pattern is associated with the development of brain metastases and the reduction of survival time in EGFR-mutation lung adenocarcinoma patients with surgery.
Li C; Shen Y; Hu F; Chu T; Yang X; Shao J; Zheng X; Xu J; Zhang H; Han B; Zhong H; Zhang X
Lung Cancer; 2020 Mar; 141():72-77. PubMed ID: 31955003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]